Publication | Closed Access

Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment

Breast OncologyImmunologyTumor ImmunityBreast CancerTumor TargetingTriple-negative Breast CancerTgf-β SirnaImmunotherapyMedicineCell BiologyTumor MicroenvironmentTumor BiologyRobust Antitumor Immunity